» Articles » PMID: 24237858

Cohort Profile: Risk Evaluation of Cancers in Chinese Diabetic Individuals: a Longitudinal (REACTION) Study

Abstract

Objective: To demonstrate whether abnormal glucose metabolism (diabetes and prediabetes) is associated with increased risk for cancer in the Chinese population and to identify factors that modify the risk of cancer among individuals with abnormal glucose metabolism.

Methods: Between 2011 and 2012, 259 657 community-dwelling adults, aged 40 years and older, were recruited from 25 centers across mainland China to participant in the baseline survey of the REACTION study, with follow-up investigations performed 3, 5, and 10 years later. Detailed questionnaires about lifestyles, physical and biochemical measurement, bio-samples including serum, urine, and whole blood for DNA extraction were collected for all the participants.

Results: The mean ± standard deviation (SD) age of this cohort was 57 ± 10 years. And the prevalence of pre-existing and newly diagnosed diabetes was 10.32% and 10.57%, respectively. A total of 4511 prevalent cancer cases (988 men and 3523 women) were identified, the prevalence was 1.79. Compared to those with normal glucose metabolism, men with diabetes had a significantly lower adjusted prevalence ratio (PR) of stomach cancer (PR: 0.38, 95% CI: 0.16-0.89), and women with diabetes had significantly higher adjusted PRs of cancer of all sites (PR: 1.36, 95% CI: 1.20-1.56), and cancer of the breast (PR: 1.56, 95% CI: 1.21-2.00), the endometrium (PR: 1.58, 95% CI: 1.16-2.15), and the thyroid (PR: 1.53, 95% CI: 1.03-2.27).

Conclusion: The multi-center REACTION study has captured a broad range of data on physical, psychological and metabolic function as well as health status, biochemical and lifestyle information in 259 657 adults from the general population across the China.

Citing Articles

The triglyceride-glucose index is associated with a higher risk of hypertension: evidence from a cross-sectional study of Chinese adults and meta-analysis of epidemiology studies.

Ren X, Chen M, Lian L, Xia H, Chen W, Ge S Front Endocrinol (Lausanne). 2025; 16:1516328.

PMID: 40065994 PMC: 11891255. DOI: 10.3389/fendo.2025.1516328.


Insulin Resistance and Cancer.

Bloomgarden Z J Diabetes. 2025; 17(2):e70064.

PMID: 40008541 PMC: 11862885. DOI: 10.1111/1753-0407.70064.


Correlation of cumulative fasting blood glucose exposure with gastrointestinal cancers: A prospective cohort study.

Liu K, Wang W, Liu Y, Li J, Ma C, Tian Y Medicine (Baltimore). 2025; 104(7):e41529.

PMID: 39960953 PMC: 11835132. DOI: 10.1097/MD.0000000000041529.


Elevated fasting serum xylitol levels are associated with a lower risk of incident type 2 diabetes among individuals with prediabetes in the Chinese population.

Qi Y, Li X, Liu Y, Wang M, Wu Y, Su Q Nutr Diabetes. 2025; 15(1):3.

PMID: 39910054 PMC: 11799369. DOI: 10.1038/s41387-025-00357-y.


Exploring age and gender disparities in cardiometabolic phenotypes and lipidomic signatures among Chinese adults: a nationwide cohort study.

Jia X, Lin H, Zheng R, Wang S, Ding Y, Hu C Life Metab. 2025; 3(5):loae032.

PMID: 39872143 PMC: 11749084. DOI: 10.1093/lifemeta/loae032.